...
首页> 外文期刊>BJU international >Common prescription medication use and erectile dysfunction: Results from the Boston Area Community Health (BACH) survey
【24h】

Common prescription medication use and erectile dysfunction: Results from the Boston Area Community Health (BACH) survey

机译:常见处方药使用和勃起功能障碍:波士顿地区社区健康(BACH)调查的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To investigate the association of erectile dysfunction (ED) with commonly used medications including antihypertensive treatment (AHT), psychoactive medication and pain and anti-inflammatory medication. Subjects and Methods The Boston Area Community Health (BACH) survey used a multistage stratified design to recruit a random sample of 2301 men aged 30-79 years. ED was assessed using the five-item International Index of Erectile Function (IIEF-5). Prescription medications, captured using a combination of drug inventory and self-report with a prompt by indication, included in this analysis comprised AHT, psychoactive medication, and pain and anti-inflammatory medication. Logistic regression was used to estimate the odds ratios (ORs) of the association of medication use with ED and to adjust for potential confounders including age, comorbid conditions and sociodemographic and lifestyle factors. Results Multivariable analyses showed benzodiazepines (adjusted OR = 2.34, 95% confidence interval [CI]: 1.03, 5.31) and tricyclic antidepressants (adjusted OR = 3.35, 95% CI: 1.09, 10.27) were associated with ED, while no association was observed for serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors and atypical antipsychotics. The use of AHT, whether in monotherapy or in conjunction with other AHTs, and pain or anti-inflammatory medications were not associated with ED after accounting for confounding factors. Conclusions Results of the BACH survey suggest adverse effects of some psychoactive medications (benzodiazepines and tricyclic antidepressants). No evidence of an association of AHT or pain and anti-inflammatory medication with ED was observed.
机译:目的探讨勃起功能障碍(ED)与常用药物包括降压治疗(AHT),精神药物和止痛消炎药物之间的关系。受试者与方法波士顿地区社区健康(BACH)调查采用了多阶段分层设计,以随机抽取2301名30-79岁的男性作为样本。使用五项国际勃起功能指数(IIEF-5)评估ED。使用药物清单和自我报告结合提示提示的处方药,包括在AHT,精神药物以及止痛和消炎药中。 Logistic回归用于估计药物使用与ED的关联的比值比(OR),并调整潜在的混杂因素,包括年龄,合并症,社会人口统计学和生活方式因素。结果多变量分析显示苯二氮卓类药物(调整后的OR = 2.34,95%置信区间[CI]:1.03、5.31)和三环类抗抑郁药(调整后的OR = 3.35,95%CI:1.09、10.27)与ED相关,但未发现相关性用于5-羟色胺再摄取抑制剂/ 5-羟色胺-去甲肾上腺素再摄取抑制剂和非典型抗精神病药。在考虑了混杂因素之后,无论是在单一疗法中还是与其他AHT结合使用AHT,以及疼痛或抗炎药物均与ED无关。结论BACH调查的结果表明某些精神药物(苯二氮卓类和三环类抗抑郁药)的不良反应。没有观察到AHT或疼痛和抗炎药与ED相关的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号